| Year |
Citation |
Score |
| 2015 |
Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M. Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1448-55. PMID 25518754 DOI: 10.1038/Npp.2014.330 |
0.32 |
|
| 2011 |
Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones RT. Cocaethylene formation following ethanol and cocaine administration by different routes. Experimental and Clinical Psychopharmacology. 19: 95-104. PMID 21463066 DOI: 10.1037/A0022950 |
0.369 |
|
| 2009 |
Harris DS, Everhart T, Jacob P, Lin E, Mendelson JE, Jones RT. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. Bmc Clinical Pharmacology. 9: 13. PMID 19646280 DOI: 10.1186/1472-6904-9-13 |
0.377 |
|
| 2008 |
Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P, Jones RT. The clinical pharmacology of intranasal l-methamphetamine. Bmc Clinical Pharmacology. 8: 4. PMID 18644153 DOI: 10.1186/1472-6904-8-4 |
0.348 |
|
| 2006 |
Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT. Human pharmacology of the methamphetamine stereoisomers. Clinical Pharmacology and Therapeutics. 80: 403-20. PMID 17015058 DOI: 10.1016/J.Clpt.2006.06.013 |
0.355 |
|
| 2006 |
Harris DS, Reus VI, Wolkowitz O, Jacob P, Everhart ET, Wilson M, Mendelson JE, Jones RT. Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. Pharmacopsychiatry. 39: 100-8. PMID 16721698 DOI: 10.1055/S-2006-941483 |
0.345 |
|
| 2006 |
Mendelson J, Jones RT, Fernandez E, Karan L, Chiang N. PII-36Single dose methamphetamine reserpine interactions Clinical Pharmacology & Therapeutics. 79: 45. DOI: 10.1016/J.Clpt.2005.12.161 |
0.315 |
|
| 2005 |
Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT, Mendelson J. Pharmacokinetics of intravenous d‐ and l‐methamphetamine in healthy volunteers Clinical Pharmacology & Therapeutics. 77. DOI: 10.1016/J.Clpt.2004.12.034 |
0.327 |
|
| 2004 |
Uemura N, Nath RP, Harkey MR, Henderson GL, Mendelson J, Jones RT. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. Journal of Analytical Toxicology. 28: 253-9. PMID 15189676 DOI: 10.1093/Jat/28.4.253 |
0.326 |
|
| 2004 |
Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clinical Pharmacokinetics. 43: 329-40. PMID 15080765 DOI: 10.2165/00003088-200443050-00005 |
0.364 |
|
| 2004 |
Nath RP, McGlothlin D, Uemura N, Fernandez E, Jones RT, Mendelson JE. Cardiovascular effects of intranasal L-methamphetamine Clinical Pharmacology & Therapeutics. 75: 71. DOI: 10.1016/J.Clpt.2003.11.269 |
0.365 |
|
| 2004 |
Uemura N, Harkey MR, Nath RP, Henderson GL, Mendelson JE, Jones RT. Delayed disposition of cocaine in sweat patches and in skin blister: cocaine may migrate from plasma to sweat patches via interstitial fluid Clinical Pharmacology & Therapeutics. 75: 44. DOI: 10.1016/J.Clpt.2003.11.163 |
0.339 |
|
| 2003 |
Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug and Alcohol Dependence. 72: 169-82. PMID 14636972 DOI: 10.1016/S0376-8716(03)00200-X |
0.368 |
|
| 2003 |
Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT. The bioavailability of intranasal and smoked methamphetamine. Clinical Pharmacology and Therapeutics. 74: 475-86. PMID 14586388 DOI: 10.1016/J.Clpt.2003.08.002 |
0.322 |
|
| 2003 |
Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1677-84. PMID 12813474 DOI: 10.1038/Sj.Npp.1300223 |
0.381 |
|
| 2003 |
Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug and Alcohol Dependence. 70: S29-37. PMID 12738348 DOI: 10.1016/S0376-8716(03)00057-7 |
0.332 |
|
| 2003 |
Uemura N, Manari A, Nath RP, Harris DS, Jones RT, Mendelson JE. Three Day 12‐Hour Cocaine Infusion Produces Tolerance in Cardiovascular and Subjective Effects, But Does Not Alter Cocaine Self‐Administration Behavior in Humans Clinical Pharmacology & Therapeutics. 73: 91. DOI: 10.1016/S0009-9236(03)90690-4 |
0.347 |
|
| 2002 |
Lester L, Uemura N, Ademola J, Harkey MR, Nath RP, Kim SJ, Jerschow E, Henderson GL, Mendelson J, Jones RT. Disposition of cocaine in skin, interstitial fluid, sebum, and stratum corneum. Journal of Analytical Toxicology. 26: 547-53. PMID 12501911 DOI: 10.1093/Jat/26.8.547 |
0.324 |
|
| 2002 |
Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. 162: 396-405. PMID 12172693 DOI: 10.1007/S00213-002-1131-1 |
0.697 |
|
| 2002 |
Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT. Urine toxicology samples in cocaine treatment trials: how many need to be tested? Journal of Addictive Diseases. 21: 17-26. PMID 11916369 DOI: 10.1300/J069V21N02_02 |
0.327 |
|
| 2001 |
Vollenweider FX, Jones RT, Baggott MJ. Caveat emptor: editors beware. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 461-3. PMID 11310414 DOI: 10.1016/S0893-133X(00)00170-6 |
0.607 |
|
| 2000 |
Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 133: 969-73. PMID 11119398 DOI: 10.7326/0003-4819-133-12-200012190-00012 |
0.672 |
|
| 2000 |
Harris DS, Jones RT, Welm S, Upton RA, Lin E, Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug and Alcohol Dependence. 61: 85-94. PMID 11064186 DOI: 10.1016/S0376-8716(00)00126-5 |
0.335 |
|
| 2000 |
Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. Jama. 284: 2190. PMID 11056589 DOI: 10.1001/Jama.284.17.2190 |
0.616 |
|
| 1999 |
Nath RP, Upton RA, Everhart ET, Cheung P, Shwonek P, Jones RT, Mendelson JE. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. Journal of Clinical Pharmacology. 39: 619-23. PMID 10354966 DOI: 10.1177/00912709922008236 |
0.313 |
|
| 1999 |
Dempsey D, Jacob P, Partridge JC, Jones RT, Panganiban K, Rowbotham MC. Cocaine metabolite kinetics in the newborn. Journal of Analytical Toxicology. 23: 24-8. PMID 10022205 DOI: 10.1093/Jat/23.1.24 |
0.324 |
|
| 1999 |
Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology. 141: 37-46. PMID 9952063 DOI: 10.1007/S002130050804 |
0.684 |
|
| 1999 |
Mendelson J, Upton R, Lin E, Welm S, Jones RT. Dose proportionality of 4, 8, 16 and 32 MG sublingual buprenorphine solutions Clinical Pharmacology and Therapeutics. 65: 154. DOI: 10.1016/S0009-9236(99)80146-5 |
0.308 |
|
| 1998 |
Dempsey DA, Partridge JC, Jones RT, Rowbotham MC. Cocaine, nicotine, caffeine, and metabolite plasma concentrations in neonates. Journal of Analytical Toxicology. 22: 220-4. PMID 9602939 DOI: 10.1093/Jat/22.3.220 |
0.324 |
|
| 1998 |
Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P. Incorporation of isotopically labeled cocaine into human hair: race as a factor. Journal of Analytical Toxicology. 22: 156-65. PMID 9547413 DOI: 10.1093/Jat/22.2.156 |
0.353 |
|
| 1997 |
Delucchi KL, Jones RT, Batki SL. Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction (Abingdon, England). 92: 297-302. PMID 9219391 DOI: 10.1111/J.1360-0443.1997.Tb03199.X |
0.32 |
|
| 1997 |
Mendelson J, Jones RT, Welm S, Brown J, Batki SL. Buprenorphine and naloxone interactions in methadone maintenance patients. Biological Psychiatry. 41: 1095-101. PMID 9146820 DOI: 10.1016/S0006-3223(96)00266-1 |
0.386 |
|
| 1997 |
Mendelson J, Upton RA, Everhart ET, Jacob P, Jones RT. Bioavailability of sublingual buprenorphine. Journal of Clinical Pharmacology. 37: 31-7. PMID 9048270 DOI: 10.1177/009127009703700106 |
0.343 |
|
| 1997 |
Jacob P, Mendelson J, Everhart ET, Nath R, Baggott M, Welm S, Jones RT. Formation and elimination of cocaethylene in humans Clinical Pharmacology and Therapeutics. 61: 222. |
0.597 |
|
| 1996 |
Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P. Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. dose-response relationships. Journal of Analytical Toxicology. 20: 1-12. PMID 8837944 DOI: 10.1093/Jat/20.1.1 |
0.374 |
|
| 1996 |
Batki SL, Washburn AM, Delucchi K, Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug and Alcohol Dependence. 41: 137-42. PMID 8809502 DOI: 10.1016/0376-8716(96)01233-1 |
0.34 |
|
| 1996 |
Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clinical Pharmacology and Therapeutics. 60: 105-14. PMID 8689806 DOI: 10.1016/S0009-9236(96)90173-3 |
0.693 |
|
| 1996 |
Mendelson J, Jones RT, Upton R, Jacob P, Everhart ET. Sublingual Buprenorphine Bioavailability Clinical Pharmacology & Therapeutics. 59: 209-209. DOI: 10.1038/Sj.Clpt.1996.337 |
0.308 |
|
| 1995 |
Mendelson J, Jones RT, Upton R, Jacob P. Methamphetamine and ethanol interactions in humans. Clinical Pharmacology and Therapeutics. 57: 559-68. PMID 7768079 DOI: 10.1016/0009-9236(95)90041-1 |
0.328 |
|
| 1995 |
Eisenberg MJ, Jue J, Mendelson J, Jones RT, Schiller NB. Left ventricular morphologic features and function in nonhospitalized cocaine users: a quantitative two-dimensional echocardiographic study. American Heart Journal. 129: 941-6. PMID 7732983 DOI: 10.1016/0002-8703(95)90115-9 |
0.319 |
|
| 1993 |
Batki SL, Manfredi LB, Jacob P, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. Journal of Clinical Psychopharmacology. 13: 243-50. PMID 8376611 DOI: 10.1097/00004714-199308000-00003 |
0.362 |
|
| 1993 |
Stillman R, Jones RT, Moore D, Walker J, Welm S. Improved performance 4 hours after cocaine. Psychopharmacology. 110: 415-20. PMID 7870911 DOI: 10.1007/Bf02244647 |
0.349 |
|
| 1992 |
Henderson GL, Harkey MR, Zhou C, Jones RT. Cocaine and metabolite concentrations in the hair of South American coca chewers. Journal of Analytical Toxicology. 16: 199-201. PMID 1522717 DOI: 10.1093/Jat/16.3.199 |
0.36 |
|
| 1991 |
Ellis WS, Jones RT. Using LabVIEW to facilitate calibration and verification for respiratory impedance plethysmography. Computer Methods and Programs in Biomedicine. 36: 169-75. PMID 1773604 DOI: 10.1016/0169-2607(91)90086-9 |
0.304 |
|
| 1990 |
Jacob P, Lewis ER, Elias-Baker BA, Jones RT. A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers. Journal of Analytical Toxicology. 14: 353-7. PMID 2087095 DOI: 10.1093/Jat/14.6.353 |
0.334 |
|
| 1987 |
Jacob P, Elias-Baker BA, Jones RT, Benowitz NL. Determination of benzoylecgonine and cocaine in biologic fluids by automated gas chromatography. Journal of Chromatography. 417: 277-86. PMID 3654881 DOI: 10.1016/0378-4347(87)80121-4 |
0.314 |
|
| 1987 |
Rowbotham MC, Hooker WD, Mendelson J, Jones RT. Cocaine-calcium channel antagonist interactions. Psychopharmacology. 93: 152-4. PMID 3122247 DOI: 10.1007/Bf00179925 |
0.347 |
|
| 1987 |
Herning RI, Hooker WD, Jones RT. Cocaine effects on electroencephalographic cognitive event-related potentials and performance. Electroencephalography and Clinical Neurophysiology. 66: 34-42. PMID 2431864 DOI: 10.1016/0013-4694(87)90136-2 |
0.351 |
|
| 1985 |
Herning RI, Jones RT, Hooker WD, Mendelson J, Blackwell L. Cocaine increases EEG beta: a replication and extension of Hans Berger's historic experiments. Electroencephalography and Clinical Neurophysiology. 60: 470-7. PMID 2408845 DOI: 10.1016/0013-4694(85)91106-X |
0.369 |
|
| 1984 |
Jacob P, Elias-Baker BA, Jones RT, Benowitz NL. Determination of cocaine in plasma by automated gas chromatography. Journal of Chromatography. 306: 173-81. PMID 6715457 DOI: 10.1016/S0378-4347(00)80880-4 |
0.31 |
|
| 1984 |
Rowbotham MC, Jones RT, Benowitz NL, Jacob P. Trazodone-oral cocaine interactions. Archives of General Psychiatry. 41: 895-9. PMID 6380447 DOI: 10.1001/Archpsyc.1984.01790200077010 |
0.378 |
|
| 1983 |
Rowbotham MC, Joseph MS, Jones RT, Keil LC. Failure of naloxone to reverse apomorphine effects in humans. Psychoneuroendocrinology. 8: 95-102. PMID 6308702 DOI: 10.1016/0306-4530(83)90045-8 |
0.333 |
|
| 1981 |
Benowitz NL, Jones RT. Cardiovascular and Metabolic Considerations in Prolonged Cannabinoid Administration in Man The Journal of Clinical Pharmacology. 21. PMID 6271827 DOI: 10.1002/J.1552-4604.1981.Tb02598.X |
0.303 |
|
| 1980 |
Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J. Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction. Clinical Pharmacology and Therapeutics. 28: 115-20. PMID 7389248 DOI: 10.1038/Clpt.1980.139 |
0.302 |
|
| 1979 |
Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clinical Pharmacology and Therapeutics. 25: 440-6. PMID 428189 DOI: 10.1002/Cpt1979254440 |
0.305 |
|
| 1979 |
Bachman JA, Benowitz NL, Herning RI, Jones RT. Dissociation of autonomic and cognitive effects of THC in man. Psychopharmacology. 61: 171-5. PMID 108734 DOI: 10.1007/Bf00426733 |
0.335 |
|
| 1979 |
Herning RI, Jones RT, Peltzman DJ. Changes in human event related potentials with prolonged delta-9-tetrahydrocannabinol (THC) use Electroencephalography and Clinical Neurophysiology. 47: 556-570. PMID 91483 DOI: 10.1016/0013-4694(79)90257-8 |
0.302 |
|
| 1977 |
Benowitz NL, Jones RT. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism Antipyrine, pentobarbital, and ethanol Clinical Pharmacology and Therapeutics. 22: 259-268. PMID 891094 DOI: 10.1002/Cpt1977223259 |
0.34 |
|
| 1977 |
Benowitz NL, Jones RT. Prolonged delta-9-tetrahydrocannabinol ingestion Effects of sympathomimetic amines and autonomic blockades Clinical Pharmacology and Therapeutics. 21: 336-342. PMID 837652 DOI: 10.1002/Cpt1977213336 |
0.313 |
|
| 1970 |
Jones RT, Stone GC. Psychological studies of marijuana and alcohol in man Psychopharmacology. 18: 108-117. PMID 4943185 DOI: 10.1007/Bf00402390 |
0.301 |
|
| Show low-probability matches. |